Hester Biosciences Limited (HESTERBIO) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Hester Biosciences Limited stock ₹2,009, price ₹2,306, that is 12.9% below the price, quality 64 out of 100. Rating: overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Hester Biosciences Limited
HESTERBIO · NSEExpensive (fair value 13% below the price), but solid company and rising price: meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 14, 2026.
How to read this chart
60‑month range ₹1,245 – ₹3,180 · fair‑value band ₹1,062 – ₹3,114 · the ₹2,306 price screens above the ₹2,009 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 14, 2026.
Every Wednesday you see whether Hester Biosciences is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Hester Biosciences Limited manufactures and trades in veterinary vaccines and health products in India and internationally. It operates through two segments, Poultry Healthcare and Animal Healthcare.
Show moreShow less
The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal, fowl pox, marek's disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl typhoid, and avian encephalomyelitis.
It also offers vaccines for peste des petits ruminants, goat pox, brucella, lumpy skin disease, contagious bovine pleuropneumonia, and contagious caprine pleuropneumonia for cattle, buffalo, sheep, and goats; and diagnostic services.
In addition, the company provides animal healthcare products, such as biosecurity solutions, therapeutics, nutritional supplements, and specialised formulations to enhance animal wellness and productivity.
Further, it offers various pet care products, including gut health solutions, NSAIDs, joint care formulations, parasiticides, grooming products, and anti-infective formulations; and healthcare products, such as immune boosters, gut health enhancers, farm hygiene, vitamins, minerals, and specialty feed supplements for critical needs comprising disease prevention, growth, and nutritional balance.
Additionally, the company provides Silvectant, a hydrogen peroxide and silver nitrate solution for disinfection of poultry sheds; Hestbac, a probiotic supplement to control pathogenic bacteria; Hestflora, a combined probiotic and prebiotic formulation that supports gut health and performance; AmmoStop, a probiotic blend for odour control and respiratory comfort in poultry farms.
It also offers INACTIVATED H9N2 vaccine for low pathogenic avian influenza; ICEFT RTU, a ceftiofur formulation for uterine and bacterial infections; and Inomilk Gel, an oral calcium supplement, as well as operates diagnostic labs for poultry.
Hester Biosciences Limited was incorporated in 1987 and is headquartered in Mehsana, India.
Stock analysis
Hester Biosciences Limited (HESTERBIO) currently trades at ₹2,306, while our model-based Fair Value estimate is ₹2,009, 13% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹1,339 per share, and 0 of the 26 models we run sit above the ₹2,306 price.
Bear case: the Asset-Based group reads lowest at ₹276.06, and 26 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: ₹1,062 (bear) to ₹3,114 (bull), the price of ₹2,306 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 64/100 (solid quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Hester Biosciences Limited reported revenue of ₹3.3B in FY2026 versus ₹2.4B in FY2022, a compound +9.1%/yr. Reported net income was ₹556M in FY2026, compounding +9.1%/yr from FY2022.
Key figures
Market cap ₹21.1B (≈ $224M) Micro · P/E ratio 13.4 · P/S ratio 6.44 · EPS (TTM) ₹160.95 · Dividend yield 0.5% · Net margin 41.6% · Return on equity 16.6% · Return on assets (EBIT) 10.1% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 69 out of 100 (low confidence).
What moves the price
The share trades about 9% below its 52-week high and 84% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at −13%, HESTERBIO screens cheaper than that median.
Fair Value models
All 26 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
HESTERBIO screens overvalued: fair value 13% below the price. Compare with Merck KGaA →
Compare Hester Biosciences Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 604 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Dividend yield by industry
- EV/EBITDA by industry
- Stock screener with 62 metrics
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $83.82 | $113.53 | +35% | vs HESTERBIO |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥48.02 | ¥53.04 | +10% | vs HESTERBIO |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,868 | ₹1,983 | +6% | vs HESTERBIO |
| Haleon plc HLN | $9.17 | $8.47 | −8% | vs HESTERBIO |
| Merck KGaA MRK | €149.70 | €108.83 | −27% | vs HESTERBIO |
| Galderma Group GALD | CHF 191.00 | CHF 112.30 | −41% | vs HESTERBIO |
| Takeda Pharmaceutical Company TAK | $21.43 | $11.20 | −48% | vs HESTERBIO |
| Sandoz Group SDZ | CHF 84.60 | CHF 40.54 | −52% | vs HESTERBIO |
| Teva Pharmaceutical Industries Limited TEVA | $44.50 | $20.74 | −53% | vs HESTERBIO |
| Divi's Laboratories Limited DIVISLAB | ₹11,080 | ₹1,567 | −86% | vs HESTERBIO |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Hester Biosciences Limited (HESTERBIO) overvalued or undervalued?
What is the fair value of HESTERBIO?
What is the quality score of HESTERBIO?
What is the price target for Hester Biosciences Limited (HESTERBIO)?
What is the Hester Biosciences Limited stock forecast for 2026?
What is the revenue of Hester Biosciences Limited (HESTERBIO)?
Does Hester Biosciences Limited pay a dividend?
How much is the dividend of Hester Biosciences Limited (HESTERBIO) and when is the ex-dividend date?
What growth is priced into Hester Biosciences Limited (HESTERBIO)?
What discount rate (WACC) does the fair value of HESTERBIO use?
What is a reverse DCF?
How much growth has Hester Biosciences Limited (HESTERBIO) delivered so far?
How fast is the sector of Hester Biosciences Limited (HESTERBIO) growing?
What is the free cash flow yield of Hester Biosciences Limited (HESTERBIO)?
What is the intrinsic value of Hester Biosciences Limited (HESTERBIO)?
Is Hester Biosciences Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of HESTERBIO?
How much is Hester Biosciences Limited worth?
What do the bullish and bearish scenarios say about HESTERBIO?
What is the P/E ratio of HESTERBIO?
How solid is the balance sheet of Hester Biosciences Limited (HESTERBIO)?
How far is HESTERBIO from its 52-week high?
Which stocks are comparable to Hester Biosciences Limited?
Is Hester Biosciences Limited stock attractive at the current price?
How is the fair value of HESTERBIO calculated?
Is it still worth investing in stocks now?
What is the share price of Hester Biosciences Limited (HESTERBIO)?
What should I pay attention to with Hester Biosciences Limited right now?
Where does the earnings growth of Hester Biosciences Limited (HESTERBIO) come from?
Key figures of Hester Biosciences Limited
How large is the market capitalisation of Hester Biosciences Limited (HESTERBIO)?
What is the P/S ratio of Hester Biosciences Limited (HESTERBIO)?
What are the earnings per share of Hester Biosciences Limited (HESTERBIO)?
What is the dividend yield of Hester Biosciences Limited (HESTERBIO)?
What is the net margin of Hester Biosciences Limited (HESTERBIO)?
What is the return on equity of Hester Biosciences Limited (HESTERBIO)?
What is the EBIT return on assets of Hester Biosciences Limited (HESTERBIO)?
What is the operating margin of Hester Biosciences Limited (HESTERBIO)?
How fast is revenue growing at Hester Biosciences Limited (HESTERBIO)?
How fast are earnings growing at Hester Biosciences Limited (HESTERBIO)?
How much net debt does Hester Biosciences Limited (HESTERBIO) carry?
Watch Hester Biosciences Limited in the live analysis
One click puts Hester Biosciences Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.